Ep90: James Sabry on Partnering Amid Scientific Abundance

1

Introduction

00:00 • 2min

2

The Long Run Interview With James Sabury

01:33 • 2min

3

Fostering Trust and Relationships Over Time

04:00 • 2min

4

The Duo Citizens With the Canadian Connection

05:40 • 4min

5

Geneta and Biotec - What's Going on in Biotec?

09:25 • 4min

6

Gene Therapy

13:14 • 3min

7

Business Development

16:05 • 2min

8

The Advantage of Having a Business Development Group

17:49 • 4min

9

Biote Companies Are a Buyer's Market

21:32 • 3min

10

A Sales Pitch for WY Partner With Ganente

24:34 • 5min

11

Biotec Journalists - Sponsoring the Long Run

29:09 • 2min

12

How Doyo, How Do You Keep, How Can You Keep?

31:29 • 3min

13

Is There a Future for Small Molecules?

34:10 • 2min

14

The Long Term Game Is Not Unimportant

36:02 • 3min

15

Jean Therapy Is One of the Major Mainstays of Treating Disease

38:46 • 2min

16

Gene Therapy

40:42 • 4min

17

Gene Therapy

44:42 • 3min

18

How Has the Power Dynamic Shifted?

48:00 • 3min

19

The Attractiveness of Early Stage Deals

51:00 • 2min

20

Is That a Key Metric of Success?

53:01 • 2min

21

The Future of the Industry

55:06 • 2min

22

The Beauty of Reading and Thinking

57:29 • 3min

23

The Long Run, a Production of Timbermen Report

01:00:15 • 33sec